USD 1.38 Billion
Cell Viability Assays Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Application (Basic Research, Stem Cell Research), By End Users, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2315 |
Region:
Global |
Published Date: November, 2024
Pages:
194
|Tables:
117
|Figures:
78
Cell Viability Assays Market Insights
Cell Viability Assays Market size was valued at USD 1.52 Billion in 2023 and is poised to grow from USD 1.67 Billion in 2024 to USD 3.56 Billion by 2032, growing at a CAGR of 9.94% during the forecast period (2025-2032).
Cell viability can be described as the presence of living or viable cells. It is considered as an indicator of good cell health. It is a viability stage that is modified because of an event of chemical or physical agents like in toxicity agents. Furthermore, cell viability assays (CVAs) are utilized for analyzing the cellular response to any pathogenic agent or drug. This is one of the reasons due to which it has found vast applications in the pharmaceutical and medical sector. the cell viability assays market is recently experiencing substantial growth due to the increasing emphasis on drug development. Cell viability assays play a vital part in early-stage drug discovery by allowing the evaluation of compound efficiency, toxicity, and safety profiles. This constant requirement for new drugs and the increasing pharma and biotechnology sectors are fueling the demand for cell viability assays market.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Consumables
Fastest Growth
Pharmaceutical and Biotechnology Companies
Growth Rate
9.94%
Global Cell Viability Assays Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Cell Viability Assays Market Segmental Analysis
Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Application Insights
Based on application insights, the cell viability assays market is segmented into stem cell research, drug discovery & development, and diagnostics. The stem cell research segment is dominating the market with the maximum revenue share. With time, stem cell therapy is becoming more advanced due to promising scientific research. The market leaders are shifting towards the advancement of novel instruments for supporting the research. In May 2022, Beckman Coulter Life Sciences introduced a unique solution AQUIOS STEM System that can be used for stem cell analysis. This advancement is helping in analyzing and counting workable cells by minimizing the manual and error-prone steps and substantially decreasing the turnaround time. Furthermore, funding related to stem cell research has increased massively in recent years, which has further accelerated the growth of research.
The drug discovery and development segment is witnessing the fastest growth in the cell viability assays market. Cell viability assays play a vital part in different stages of drug discovery and development due to their versatility, flexibility, and adaptability. Cell viability assays are essentially utilized for screening the response of the cells against a chemical compound or a drug during the drug discovery and development procedure. Furthermore, they are utilized for evaluating the cellular variations that are connected to the death of cells. This includes alterations in protein expression and loss of membrane integrity in enzymatic activity due to its contact to a test compound. These applications of cell viability assay in drug discovery and development are driving the segment.
Analysis by End Use
Based on end use, the market is segmented into biopharmaceutical & pharmaceutical companies, CROS & CMOS, academic & research institutes, diagnostic labs. The biopharmaceutical & pharmaceutical companies’ segment is dominating the cell viability assays market with maximum share. This growth is mainly due to the extensive utilization of viability assay in pharmaceuticals to evaluate the influence of developed agents on cells. Researchers are also using several kinds of assays for monitoring the impact of developed therapeutics that often target cancer tumors. Furthermore, toxicity levels of the compounds or agents can be evaluated using a cell viability assay. Such broad applications of cell viability assay in the biopharmaceutical and pharmaceutical industry are boosting the growth of the segment.
The CROs and CMOs are witnessing the fastest growth in the cell viability assays market. This is primarily because pharmaceutical organizations are entering into partnerships with CROs and CMOs for various reasons. These collaborations have the possibility to enhance process efficiency, reduce expenses, and minimize time to market. In November 2021, Hamlet Pharma went into a collaboration with CRO Galenica AB. The objective was the development of BAMLET for pharmaceutical use. BAMLET is a strong therapeutic for colon cancer and cell viability assays have applications in discovering the biological activity of the product. This can also help in the advancement of ideal drug formulation. Such partnerships are increasing the usage of cell viability assays in different applications such as drug discovery and development. This is` fueling the growth of the market.
To get detailed analysis on other segments, Request For Free Sample Report
Cell Viability Assays Market Regional Insights
North America is dominating the cell viability assays market with maximum market revenue. This dramatic surge in the market is mainly due to increasing incidences of chronic diseases like cancer, cardiovascular, diabetes, neurological disorders, osteoarthritis, diabetes and others. Furthermore, factors like advanced medical structures and the presence of prominent market players are also fueling the growth of the market. Many companies are also investing increasingly in R&D, which is positively influencing market growth. Increasing adoption of cell-based assays is also boosting the demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of the market in the region. Moreover, many market players are emphasizing on partnerships or strategic collaborations for the advancement of cell-based assays in the region.
The Asia Pacific region is witnessing substantial growth in the cell viability market. This growth is mainly because of a surge in research and development activities in the field of life sciences and biotechnology. Many governments bodies, academic facilities, and private organizations are investing in research infrastructure and encouraging collaborations. This has resulted into the expansion of cell-based assay research, boosting the market's growth. Furthermore, Asia Pacific region is witnessing an increasing incidence of chronic diseases like cancer, cardiovascular diseases, and diabetes. Cell-based assays are also playing a vital part in analyzing disease mechanisms, detecting possible therapeutic targets, and testing drug efficiency. The requirement for effective diagnostics and personalized medicine methods are also fueling the adoption of cell-based assays in the region.
Global Cell Viability Assays Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cell Viability Assays Market Dynamics
Drivers
Expansion of Drug Discovery and Development
- Manufacturers are constantly investing in research and development for introducing new drugs to treat various conditions in patients. The pharmaceutical and biotechnology sectors are immensely dependent on cell viability assays for drug discovery, toxicity testing, and efficiency evaluation. The development in these sectors is constantly boosting demand for advanced assays.
Increasing Expansion of Stem Cell Research
- Cell viability assays are increasing in various fields due to extensive research. The growing field of stem cell research and regenerative medicine is increasing demand for cell viability assays tools. These devices can be utilized for assessing cell proliferation, differentiation, and feasibility in stem cell cultures. This is boosting the market dynamics and increasing adoption among research laboratories and academic facilities.
Restraints
High Expense of Instruments
- The high expense of instruments for cell viability is becoming a major restraint for the cell viability assays market. This is mainly true for startup medical providers or businesses with limited funds to invest. Along with this the lack of professionals and technical experts to operate these instruments is also hampering the growth of the market. This is because with limited funds it is not possible for small businesses to hire a skilled workforce.
Strict Regulations on Using Reagents
- The strict restrictions on utilization of reagents hamper the development of the cell viability assay market. Furthermore, the high expenses of instruments will restrict the expansion of the market. Some cell-based assays need particular reagents, like antibodies, growth factors, cytokines, or fluorescent dyes, for detecting and measuring cellular responses. Such specialized reagents may be subject to restrictions because of intellectual property rights, licensing agreements, or restricted commercial availability.
Request Free Customization of this report to help us to meet your business objectives.
Cell Viability Assays Market Competitive Landscape
The cell viability assays market is growing as prominent players are developing advanced assays technologies like novel reagents, assay kits, and platforms. This includes creating more physiologically applicable cell models to enhance assay sensitivity and improve automation and data analysis abilities. Organizations are also extending their product line to fulfill the requirement of a vast range of applications. These consist of providing assays customized for specific targets, pathways, and disease models. It can also help in creating specialized kits for toxicity testing and drug screening. Manufacturers are also offering customized assay development services and are working with clients to tailor assays to their specific research needs, boosting market growth.
Top Player’s Company Profile
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Lonza Group AG
- Promega Corporation
- Charles River Laboratories International, Inc.
- Menarini Silicon Biosystems, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Macrogen Inc
- DiscoverX Corporation
- Corning Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Perkinelmer, Inc.
- Biognosys
- Cell Signaling Technology, Inc.
- Lebermuth, Inc.
- Eurofins DiscoverX Products
- AAT Bioquest, Inc.
- GE Healthcare
- Beckman Coulter,Inc.
Recent Developments
- In March 2022, Promega Corporation went into a strategic collaboration with FUJIFILM Cellular Dynamics, Inc. The objective is to ensure the advancement of novel assay development for drug discovery.
- In 2022, BD launched the BD Rhapsody TCR/BCR Multiomic Assay. This is an advanced set of reagents that allows researchers to more easily and widely analyze vital cells in the immune system.
- In August 2022, LifeNet Health LifeSciences launched their advanced cell-based assay services platform. The organization has introduced a new service under the acquired activity of IONTOX.
Cell Viability Assays Key Market Trends
- Increasing Technological Development: Continuous innovations in the characteristics of the cell viability assays are propelling market growth. Manufacturers are now incorporating cell viability assays with other emerging technologies, like artificial intelligence (AI) and machine learning. This is immensely improving data analysis, interpretation, and overall, the performance of assay. These advancements are also further progressing the growth of cello viability assays market.
- Growing Demand for Personalized Medicines : Cell viability assays can contribute to the trend of personalized medicine by offering individualized drugs and treatment planning strategies. With the increasing popularity of personalized there will be an increasing need for cell viability assays customized for specific patient profiles. Personalized medicines can help physicians to provide better treatment to the patients as they can better understand the diseases. This is creating more opportunities for the cell viability assays market.
Cell Viability Assays Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global cell viability assays market is growing exponentially as it can be utilized during drug development processes. This can check whether the developed drug is valuable for the treatment of diseases. The increasing prevalence of chronic diseases is boosting research activities for treating these diseases, which is fueling the cell viability assays market. The growth of infectious diseases is also driving the development of the market. Furthermore, governments are also making huge investments for drug development, accelerating cell-based research activities, leading to the growth of the cell viability assays market.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.38 Billion |
| Market size value in 2031 | USD 3.24 Billion |
| Growth Rate | 9.94% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Cell Viability Assays Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Cell Viability Assays Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Cell Viability Assays Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Viability Assays Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Viability Assays Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Viability Assays Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
